Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
Authors
Keywords
-
Journal
SCIENCE
Volume 374, Issue 6575, Pages 1626-1632
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-12-24
DOI
10.1126/science.abl6184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein
- (2021) Shan Lu et al. Nature Communications
- Engineering SARS-CoV-2 using a reverse genetic system
- (2021) Xuping Xie et al. Nature Protocols
- A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
- (2021) Suzannah J. Rihn et al. PLOS BIOLOGY
- A novel cell culture system modeling the SARS-CoV-2 life cycle
- (2021) Xiaohui Ju et al. PLoS Pathogens
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
- (2021) Xianding Deng et al. CELL
- SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
- (2021) Alona Kuzmina et al. Cell Host & Microbe
- The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA
- (2021) Jasmine Cubuk et al. Nature Communications
- Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
- (2021) Shiho Torii et al. Cell Reports
- SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
- (2021) Chihiro Motozono et al. Cell Host & Microbe
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
- (2021) Raj Kalkeri et al. Microorganisms
- The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
- (2021) Yang Liu et al. NATURE
- An Infectious cDNA Clone of SARS-CoV-2
- (2020) Xuping Xie et al. Cell Host & Microbe
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Biochemical characterization of SARS-CoV-2 nucleocapsid protein
- (2020) Weihong Zeng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
- (2020) Jing Lu et al. CELL RESEARCH
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome
- (2020) Chengjin Ye et al. mBio
- SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs
- (2020) Theodora Myrto Perdikari et al. EMBO JOURNAL
- Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions
- (2020) Christopher R. Carlson et al. MOLECULAR CELL
- Minimal system for assembly of SARS-CoV-2 virus like particles
- (2020) Heather Swann et al. Scientific Reports
- The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles
- (2016) Makoto Ujike et al. JOURNAL OF GENERAL VIROLOGY
- Functional Analysis of the Murine Coronavirus Genomic RNA Packaging Signal
- (2013) L. Kuo et al. JOURNAL OF VIROLOGY
- The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles
- (2008) Y. L. Siu et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started